Business Context and Reporting Period
This Form 8-K was filed by AmerisourceBergen Corporation (now Cencora, Inc.) on October 16, 2020. The report details the entry into material definitive agreements regarding the company's securitization facility.
Key Financial Metrics and Liquidity
The filing focuses on liquidity arrangements rather than operational financial results. Key metrics include:
- Securitization Facility Base Limit: US$1,450 million.
- Seasonal Expansion Option: An additional US$250 million available during December and March quarters, subject to bank approval.
- Collateral: Accounts receivables originated by AmerisourceBergen Drug Corporation (ABDC) and ASD Specialty Healthcare, LLC (ASD) from pharmaceutical sales and related services.
Material Changes
On October 16, 2020, the Company executed three amendments to its existing financing structure:
- New Originator: ASD Specialty Healthcare, LLC was added as a new originator under the securitization facility, allowing for the sale of its trade receivables.
- Interest Rate Benchmark Transition: Provisions were added to transition to a new interest rate benchmark when LIBOR ceases to be available.
- Performance Guarantee: The Company executed a Second Amended and Restated Performance Undertaking, serving as the performance guarantor for ASD's obligations as an originator and ABDC's obligations as an originator and servicer.
Outlook, Risks, and Management Commentary
The amendments are designed to provide additional liquidity and funding for the ongoing business needs of the Company and its subsidiaries. The filing notes that the Company guarantees the performance of its subsidiaries under the facility. No specific forward-looking guidance, risk factors, or unusual items were disclosed in this specific report beyond the structural changes to the financing agreement.
Investor Verification Checklist
- Verify the exact terms of the LIBOR transition benchmark specified in the amendments.
- Confirm the utilization rate of the US$1,450 million base limit and the US$250 million seasonal option.
- Review the full text of Exhibits 10.1, 10.2, and 10.3 for detailed covenants and conditions.
- Assess the credit quality of the new receivables pool originating from ASD Specialty Healthcare, LLC.